Specify a stock or a cryptocurrency in the search bar to get a summary
Mayinglong Pharmaceutical Group Co Ltd
600993Mayinglong Pharmaceutical Group Co., LTD. engages in the manufacture, wholesale, and retail of pharmaceutical products primarily in China. The company products pipeline primarily consists of functional cosmetics, functional care products, functional food, and Chinese herbal medicines, as well as hemorrhoid, gynecological, cough, and skin products; and medical instruments. It is also involved in the retail and wholesale of medical devices and drugs; provision of hospital medical services; and operation of hospitals. The company sells its products through online channels. Mayinglong Pharmaceutical Group Co., LTD. was founded in 1582 and is headquartered in Wuhan, China. Address: No. 100, Zhoujiawan, Wuhan, China, 430064
Analytics
WallStreet Target Price
147.9 CNYP/E ratio
23.0268Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 600993
Dividend Analytics 600993
Dividend growth over 5 years
52 %Continuous growth
–Payout Ratio 5 years average
28 %Dividend History 600993
Stock Valuation 600993
Financials 600993
Results | 2019 | Dynamics |